Previous 10 | Next 10 |
home / stock / cqpty / cqpty news
CollPlant Biotechnologies Reports Third Quarter (Q3) 2020 Financial Results and Provides Business Update - Expanded collaboration agreement with United Therapeutics which exercised its option for 3D bioprinted kidney transplants and $3 million payment to CollPlant - Increase...
CollPlant Announces Early Development Program of Antiviral Agent for Potential Treatment of COVID-19 Patients Pre-clinical results show significant inhibition of avian coronavirus infectivity when treated with CollPlant's novel approach PR Newswire REHOVOT, Israel, Nov. ...
CollPlant Receives Substantial First Order for its Vergenix™ Flowable Gel Product in Ukraine Order worth hundreds of thousands of U.S. dollars following regulatory approval in Ukraine PR Newswire REHOVOT, Israel, Oct. 26, 2020 REHOVOT, Israel , Oct. ...
CollPlant and United Therapeutics Announce Exercise of Option that will Expand their Collaboration to Include 3D Bioprinting of Human Kidneys for Transplant Expanded collaboration combines CollPlant's proprietary BioInk that is based on its recombinant human collagen (rhCollagen...
REHOVOT, Israel , Sept. 16, 2020 /PRNewswire/ -- CollPlant (NASDAQ: CLGN) a regenerative and aesthetic medicine company, today announced that Dr. Nadav Orr , Vice President of R&D, presented a corporate overview on the dynamics of cellular aging during Session 3 of the Science ...
REHOVOT, Israel , Sept. 14, 2020 /PRNewswire/ -- CollPlant has already received first order amounting to hundreds of thousands of U.S. dollars Product distribution in six CIS countries expected to increase clinical use in new patient populations Recent peer-reviewed pu...
REHOVOT, Israel , Aug. 31, 2020 /PRNewswire/ -- CollPlant (NASDAQ: CLGN) a regenerative and aesthetic medicine company, today announced that Dr. Nadav Orr , Vice President of R&D, will be presenting at the Science of Aging Virtual Symposium 2020 . The event will be held virtual...
REHOVOT, Israel , Aug. 28, 2020 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetics medicine company, today announced financial results for the second quarter ended June 30, 2020 and provided an update on the Company's business developments. Certain metrics, includ...
REHOVOT, Israel , May 27, 2020 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetics medicine company, today announced financial results for the first quarter ended March 31, 2020 and provided an update on the Company's business developments. Certain metrics, in...
REHOVOT, Israel , May 5, 2020 /PRNewswire/ -- CollPlant (NASDAQ:CLGN) , a regenerative and aesthetics medicine company, today announced that it will be hosting a webinar on Tuesday, May 12, 2020 at 11 am EDT / 6 pm IDT that will feature its Co-Founder and Chief Scientist, Professor ...
News, Short Squeeze, Breakout and More Instantly...
Collplant Holdings Company Name:
CQPTY Stock Symbol:
OTCMKTS Market:
Termination of Licensing Agreement for Bioprinting of Scaffolds for Lung Transplants PR Newswire REHOVOT, Israel , Feb. 25, 2021 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN) a regenerative and aesthetics medicine company, today announced that on ...